MktsMarkets

Amylyx Pharmaceuticals, Inc.
NASDAQ: AMLXKey statistics
AMLX News
Stories mentioning AMLX from around the web — every one is an open thread, so give it a like or add your take.
Loading news…
Financial statements
As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.
| Line item | Q1 '26Mar 31 | Q4 '25Dec 31 | Q3 '25Sep 30 | Q2 '25Jun 30 | Q1 '25Mar 31 | Q4 '24Dec 31 | Q3 '24Sep 30 | Q2 '24Jun 30 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | (665.00) | 416.00 | (1,023) | |
| Cost of Goods Sold | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 8.00 | |
| Gross Profit | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 416.00 | ||
| Operating Expenses | ||||||||
| Research & Development | 27,610 | 21,213 | 19,855 | 27,217 | 22,119 | 22,892 | 21,237 | 23,347 |
| Sales General & Admin | 16,169 | 15,391 | 16,172 | 15,640 | 15,684 | 17,097 | 17,828 | 21,647 |
| Total Operating Expenses | ||||||||
| Operating Income (Loss) | (43,779) | (36,604) | (36,027) | (42,857) | (37,803) | (40,654) | (75,661) | (76,286) |
| Interest Income | 2,570 | 3,290 | 1,821 | 1,960 | 2,231 | 2,316 | 3,098 | 4,069 |
| Interest Expense | ||||||||
| Other Expense | (75.00) | 361.00 | (180.00) | (546.00) | (335.00) | 157.00 | (141.00) | (483.00) |
| Pretax Income | (32,953) | (34,386) | (41,443) | (35,907) | (38,181) | (72,704) | (72,700) | |
| Tax Provision | 46.00 | 0.00 | 0.00 | 0.00 | (635.00) | 0.00 | 0.00 | |
| Net Income (Loss) | (41,284) | (32,999) | (34,386) | (41,443) | (35,907) | (37,546) | (72,704) | (72,700) |
| Earnings Per Share (Basic) | (0.37) | (0.35) | (0.37) | (0.46) | (0.42) | (0.55) | (1.07) | (1.07) |
| Earnings Per Share (Diluted) | (0.37) | (0.35) | (0.37) | (0.46) | (0.42) | (0.55) | (1.07) | (1.07) |
| Weighted Average Shares Outstanding (Basic) | 110,563 | 94,566 | 93,333 | 89,139 | 85,697 | 68,142 | 68,091 | 68,025 |
| Weighted Average Shares Outstanding (Diluted) | 110,563 | 94,566 | 93,333 | 89,139 | 85,697 | 68,142 | 68,091 | 68,025 |
Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.
About AMLX
Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX) is a stock listed on the Nasdaq Stock Market under the ticker symbol AMLX. It last traded at $26.62 (Nov 18, 2026, 4:00 PM ET), down 3.3% on the day. That gives Amylyx Pharmaceuticals a market capitalisation of $3.4B.
Over the past 52 weeks AMLX has traded between $10.83 and $41.14.
For the quarter ended Mar 31, 2026 it reported a net loss of $41.3M.
| Quarter ended | Revenue | Net income |
|---|---|---|
| Mar 31, 2026 | — | -$41.3M |
| Dec 31, 2025 | $0 | -$33.0M |
| Sep 30, 2025 | $0 | -$34.4M |
| Jun 30, 2025 | $0 | -$41.4M |
From Amylyx Pharmaceuticals’s quarterly (10-Q) filings, in US dollars.
Take a break — play a market game
Seven free games built around the markets. No download, no sign-up: they run right here in your browser.
Latest News
Market news from around the web — every story is an open thread, so give it a like or add your take.
Loading news…